Novo Nordisk A/SNVONYSE
Loading
Cash Flow PerformanceNormalizing
Percentile Rank71
3Y CAGR+10.6%
5Y CAGR+6.3%
Year-over-Year Change
Free cash flow yield
3Y CAGR
+10.6%/yr
vs -8.9%/yr prior
5Y CAGR
+6.3%/yr
Recent acceleration
Acceleration
+19.4pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.08% | +62.8% |
| 2024 | 2.51% | +12.0% |
| 2023 | 2.24% | -25.9% |
| 2022 | 3.02% | +7.0% |
| 2021 | 2.82% | -6.0% |
| 2020 | 3.00% | -22.5% |
| 2019 | 3.87% | -11.5% |
| 2018 | 4.37% | +11.1% |
| 2017 | 3.94% | -36.6% |
| 2016 | 6.21% | - |